Guest guest Posted February 24, 2010 Report Share Posted February 24, 2010 " ScienceDaily (June 8, 2009) — In the battle against cancer, allies can come from unexpected sources. Research at The Laboratory has yielded a new approach to treating leukemia, one that targets leukemia-proliferating cells with drugs that are already on the market. " Li also treated mice with CML with Zileuton, an asthma medication that inhibits the Alox5 inflammation pathway, as well imatinib, commonly known as Gleevec, the most effective current leukemia medication. Imatinib effectively treated CML, but Zileuton was more effective. The two drugs combined provided an even better therapeutic effect. The Laboratory is seeking patent protection on the novel approach to treat CML that Li and colleagues have demonstrated. ' Story Source: Adapted from materials provided by Laboratory, via EurekAlert!, a service of AAAS. http://www.sciencedaily.com/releases/2009/06/090607153256.htm FYI, Lottie Duthu Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.